生物
染色质重塑
前额叶皮质
遗传学
染色质
单核苷酸多态性
脉冲前抑制
神经科学
精神分裂症(面向对象编程)
基因
医学
精神科
基因型
认知
作者
Minori Koga,Hiroki Ishiguro,Saori Yazaki,Yasue Horiuchi,Makoto Arai,Kazuhiro Niizato,Shuji Iritani,Masanari Itokawa,Toshiya Inada,Nakao Iwata,Norio Ozaki,Hiroshi Ujike,Hiroshi Kunugi,Tsukasa Sasaki,Makoto Takahashi,Yuichiro Watanabe,Toshiyuki Someya,Akiyoshi Kakita,Hitoshi Takahashi,Hiroyuki Nawa
摘要
Chromatin remodeling may play a role in the neurobiology of schizophrenia and the process, therefore, may be considered as a therapeutic target. The SMARCA2 gene encodes BRM in the SWI/SNF chromatin-remodeling complex, and associations of single nucleotide polymorphisms (SNPs) to schizophrenia were found in two linkage disequilibrium blocks in the SMARCA2 gene after screening of 11 883 SNPs (rs2296212; overall allelic P = 5.8 × 10−5) and subsequent screening of 22 genes involved in chromatin remodeling (rs3793490; overall allelic P = 2.0 × 10−6) in a Japanese population. A risk allele of a missense polymorphism (rs2296212) induced a lower nuclear localization efficiency of BRM, and risk alleles of intronic polymorphisms (rs3763627 and rs3793490) were associated with low SMARCA2 expression levels in the postmortem prefrontal cortex. A significant correlation in the fold changes of gene expression from schizophrenic prefrontal cortex (from the Stanley Medical Research Institute online genomics database) was seen with suppression of SMARCA2 in transfected human cells by specific siRNA, and of orthologous genes in the prefrontal cortex of Smarca2 knockout mice. Smarca2 knockout mice showed impaired social interaction and prepulse inhibition. Psychotogenic drugs lowered Smarca2 expression while antipsychotic drugs increased it in the mouse brain. These findings support the existence of a role for BRM in the pathophysiology of schizophrenia.
科研通智能强力驱动
Strongly Powered by AbleSci AI